News Roundup | Dr. Tess Lawrie Discusses her Ivermectin Meta-Analysis, the FDA, and Dr. Andrew Hill

An interview with Dr. Tess Lawrie. We discuss the ongoing saga surrounding her meta-analysis on Ivermectin studies for the safety and efficacy against Covid-19. We also touch on the FDA recent announcement cautioning against the use of the drug, and Dr. Andrew Hill.

Dr. Lawrie is the director of E-BMC Ltd. and is committed to improving the quality of healthcare through rigorous research. She is a frequent member of technical teams responsible for developing international guidelines. Her peer-reviewed publications have received in excess of 3000 citations and her ResearchGate score is among the top 5% pf ResearchGate members.


Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee